United States Rheumatic Heart Disease Market was valued at USD 0.85 Billion in 2022 and is projected to reach USD 1.29 Billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030.
Rheumatic heart disease (RHD) continues to be a significant health concern in the United States, particularly among those with a history of untreated or poorly managed strep throat or scarlet fever. The market for RHD treatments and solutions is growing steadily, driven by increased awareness, advancements in medical technologies, and the rising need for early diagnosis and effective management strategies. This article explores the key factors shaping the US rheumatic heart disease market, the types of treatments available, and the industries' requirements to address this critical health issue.
RHD is a serious condition where the heart valves are damaged due to an immune response following a streptococcal throat infection. The demand for RHD-related healthcare services has surged as the number of diagnosed cases increases. The US market primarily consists of pharmaceuticals, medical devices, diagnostic tools, and rehabilitation services. Among the available treatments, medications for secondary prevention of streptococcal infections, such as penicillin and corticosteroids, are commonly prescribed to prevent disease progression and recurrence.
Medical device manufacturers and healthcare providers are also focusing on advanced diagnostics and imaging tools for more accurate and timely detection of RHD. Echo cardiography is a key diagnostic tool that helps in identifying valve abnormalities. Furthermore, healthcare providers are turning towards AI-powered imaging systems to improve diagnosis accuracy, which is expected to boost the market's growth potential.
Moreover, the increasing need for long-term follow-up care and rehabilitation services highlights the industry's expanding requirements. There is a demand for more integrated solutions that combine diagnostics, treatment, and patient management, aiming for better outcomes and reduced healthcare costs. As this sector evolves, the industry is also seeking enhanced patient education programs and more accessible healthcare facilities, especially in rural and underserved areas.
The US rheumatic heart disease market is closely tied to innovations in healthcare infrastructure and technology, with industries increasingly relying on new diagnostic tools, treatments, and preventive measures. In this growing market, it is clear that meeting the needs of RHD patients requires multi-faceted collaboration between healthcare providers, medical device manufacturers, and pharmaceutical companies to ensure that quality care is delivered to all patients.
Get an In-Depth Research Analysis of the US Rheumatic Heart Disease Market Size And Forecast [2025-2032]
Abbott Laboratories
Bayer
BIOTRONIK
Boston Scientific
Bristol-Myers Squibb
C. R. Bard
Cardinal Health
Cook Medical
Roche
GE Healthcare
InterValve
Novartis
On-X Life Technologies
Osypka Medical
Otsuka
PerkinElmer
Pfizer
Reckitt Benckiser
Siemens Healthineers
Toray
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Rheumatic Heart Disease Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Rheumatic Heart Disease Market
Medications
Medical Devices
Oral
Parenteral
Topical
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Direct Sales
Pediatric (0-14 years)
Adolescent (15-24 years)
Adult (25-64 years)
Geriatric (65 years and above)
Early Stage
Moderate Stage
Severe Stage
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Rheumatic Heart Disease Market Research Analysis
1. Introduction of the US Rheumatic Heart Disease Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Rheumatic Heart Disease Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Rheumatic Heart Disease Market, By Type
6. US Rheumatic Heart Disease Market, By Application
7. US Rheumatic Heart Disease Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Rheumatic Heart Disease Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/